LifeStance Health Group (NASDAQ:LFST) Stock Price Expected to Rise, BTIG Research Analyst Says

LifeStance Health Group (NASDAQ:LFST) had its target price lifted by equities research analysts at BTIG Research from $16.00 to $18.00 in a research report issued on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. BTIG Research’s price target indicates a potential upside of 45.63% from the stock’s previous close.

LFST has been the topic of a number of other reports. KeyCorp lifted their price objective on shares of LifeStance Health Group from $11.00 to $13.00 and gave the company an “overweight” rating in a research note on Monday, July 13th. Weiss Ratings upgraded shares of LifeStance Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, August 11th. The Goldman Sachs Group began coverage on shares of LifeStance Health Group in a research note on Friday, June 5th. They issued a “neutral” rating and a $9.00 price target for the company. Zacks Research cut shares of LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a report on Monday, July 13th. Finally, Canaccord Genuity Group raised their price objective on shares of LifeStance Health Group from $11.00 to $13.00 and gave the company a “buy” rating in a research note on Tuesday, July 21st. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, LifeStance Health Group currently has an average rating of “Moderate Buy” and a consensus price target of $12.38.

LifeStance Health Group Stock Performance

Shares of NASDAQ LFST opened at $12.36 on Wednesday. The company has a current ratio of 1.38, a quick ratio of 1.38 and a debt-to-equity ratio of 0.18. The stock has a 50 day simple moving average of $10.58 and a 200-day simple moving average of $8.30. The company has a market cap of $4.79 billion, a PE ratio of 95.08 and a beta of 1.14. LifeStance Health Group has a 12-month low of $4.77 and a 12-month high of $12.76.

LifeStance Health Group (NASDAQ:LFST) last posted its earnings results on Thursday, August 6th. The company reported $0.06 EPS for the quarter, beating the consensus estimate of $0.03 by $0.03. The firm had revenue of $435.35 million for the quarter, compared to analysts’ expectations of $414.58 million. LifeStance Health Group had a return on equity of 3.39% and a net margin of 3.19%.The firm’s revenue was up 26.1% compared to the same quarter last year. During the same period last year, the firm earned ($0.01) EPS. On average, equities research analysts forecast that LifeStance Health Group will post 0.16 EPS for the current year.

Insider Transactions at LifeStance Health Group

In related news, COO Lisa K. Miller sold 47,912 shares of the firm’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $10.85, for a total transaction of $519,845.20. Following the completion of the transaction, the chief operating officer owned 281,289 shares of the company’s stock, valued at $3,051,985.65. This trade represents a 14.55% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, major shareholder Tpg Gp A, Llc sold 13,643,207 shares of LifeStance Health Group stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $10.62, for a total value of $144,890,858.34. Following the transaction, the insider directly owned 98,101,407 shares in the company, valued at approximately $1,041,836,942.34. The trade was a 12.21% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 14,629,850 shares of company stock worth $154,952,012. Corporate insiders own 3.50% of the company’s stock.

Institutional Trading of LifeStance Health Group

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Larson Financial Group LLC boosted its holdings in LifeStance Health Group by 19,952.6% during the fourth quarter. Larson Financial Group LLC now owns 3,810 shares of the company’s stock worth $27,000 after buying an additional 3,791 shares in the last quarter. KBC Group NV acquired a new stake in shares of LifeStance Health Group during the 1st quarter valued at $29,000. EverSource Wealth Advisors LLC boosted its stake in shares of LifeStance Health Group by 359.1% during the 1st quarter. EverSource Wealth Advisors LLC now owns 6,909 shares of the company’s stock worth $44,000 after acquiring an additional 5,404 shares in the last quarter. Bayesian Capital Management LP acquired a new position in shares of LifeStance Health Group in the 2nd quarter worth $52,000. Finally, PNC Financial Services Group Inc. raised its position in shares of LifeStance Health Group by 615.3% during the first quarter. PNC Financial Services Group Inc. now owns 9,285 shares of the company’s stock worth $59,000 after purchasing an additional 7,987 shares during the period. 85.50% of the stock is currently owned by institutional investors.

LifeStance Health Group Company Profile

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.